MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ACH — Accendra Health, Inc.
NYSEAccendra Health, Inc.
$0.56
-0.00(-0.87%)
- O
- 0.58
- H
- 0.59
- L
- 0.55
- V
- 1.53M
⏱️ End-of-day dataAs of Oct 1, 2026
Accendra Health, Inc. Statistics
Total Valuation
| Market Cap | $54.45M |
| Enterprise Value | $179.70M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | 76.90M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 10.02 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -27.78 |
| EV / Sales | n/a |
| EV / EBITDA | 2.15 |
| EV / EBIT | 11.16 |
| EV / FCF | -1.94 |
Financial Position
| Current Ratio | 0.49 |
| Quick Ratio | n/a |
| Debt / Equity | -3.42 |
| Debt / EBITDA | 1.90 |
| Debt / FCF | -1.72 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | 13.92% |
| Return on Assets (ROA) | -2.68% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-995 |
| Employee Count | 6,500 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -$9.78M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | -88.89% |
| 50-Day Moving Average | $1.54 |
| 200-Day Moving Average | $2.48 |
| Relative Strength Index (RSI) | 6.64 |
| Average Volume (20 Days) | 1,354,337 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | $27.80M |
| Operating Income | $22.80M |
| Pretax Income | -$16.25M |
| Net Income | -$6.47M |
| EBITDA | $83.52M |
| EBIT | $16.10M |
| Loss Per Share | $-0.08 |
Balance Sheet
| Cash & Cash Equivalents | $33.69M |
| Total Debt | $158.94M |
| Net Cash | -$125.25M |
| Net Cash Per Share | $-1.63 |
| Equity (Book Value) | -$46.48M |
| Book Value Per Share | $-0.60 |
| Working Capital | -$61.46M |
Cash Flow
| Operating Cash Flow | $5.43M |
| Capital Expenditures | $54.77M |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -$92.57M |
| FCF Per Share | $-1.20 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | -170.01% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |